Form 8-K - Current report:
SEC Accession No. 0001829126-25-002295
Filing Date
2025-04-01
Accepted
2025-04-01 17:00:20
Documents
15
Period of Report
2025-03-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neonctechnologies_8k.htm   iXBRL 8-K 28087
2 EXHIBIT 10.1 neonctechnologies_ex10-1.htm EX-10.1 183089
3 EXHIBIT 99.1 neonctechnologies_ex99-1.htm EX-99.1 11793
  Complete submission text file 0001829126-25-002295.txt   440319

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cik0001979414-20250326.xsd EX-101.SCH 3044
5 XBRL LABEL FILE cik0001979414-20250326_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE cik0001979414-20250326_pre.xml EX-101.PRE 22369
17 EXTRACTED XBRL INSTANCE DOCUMENT neonctechnologies_8k_htm.xml XML 3689
Mailing Address 2 DOLE DRIVE WESTLAKE VILLAGE CA 91362
Business Address 2 DOLE DRIVE WESTLAKE VILLAGE CA 91362 310 663 7831
NEONC TECHNOLOGIES HOLDINGS, INC. (Filer) CIK: 0001979414 (see all company filings)

EIN.: 921954864 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42567 | Film No.: 25800635
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)